BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20971078)

  • 1. Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.
    Hocking LJ; Mellis DJ; McCabe PS; Helfrich MH; Rogers MJ
    Biochem Biophys Res Commun; 2010 Nov; 402(3):543-8. PubMed ID: 20971078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
    Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
    J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
    Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
    Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
    Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
    J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
    Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH
    J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy.
    Clausen TH; Lamark T; Isakson P; Finley K; Larsen KB; Brech A; Øvervatn A; Stenmark H; Bjørkøy G; Simonsen A; Johansen T
    Autophagy; 2010 Apr; 6(3):330-44. PubMed ID: 20168092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.
    Collet C; Michou L; Audran M; Chasseigneaux S; Hilliquin P; Bardin T; Lemaire I; Cornélis F; Launay JM; Orcel P; Laplanche JL
    J Bone Miner Res; 2007 Feb; 22(2):310-7. PubMed ID: 17129171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
    Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
    Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations.
    Cavey JR; Ralston SH; Hocking LJ; Sheppard PW; Ciani B; Searle MS; Layfield R
    J Bone Miner Res; 2005 Apr; 20(4):619-24. PubMed ID: 15765181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
    Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
    J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
    Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
    Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
    Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
    Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
    Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
    J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p62 mutations, ubiquitin recognition and Paget's disease of bone.
    Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERADication of EDEM1 occurs by selective autophagy and requires deglycosylation by cytoplasmic peptide N-glycanase.
    Park S; Jang I; Zuber C; Lee Y; Cho JW; Matsuo I; Ito Y; Roth J
    Histochem Cell Biol; 2014 Aug; 142(2):153-69. PubMed ID: 24664425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts.
    Chamoux E; McManus S; Laberge G; Bisson M; Roux S
    Biochim Biophys Acta; 2013 Mar; 1832(3):475-84. PubMed ID: 23266528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.